IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
47 hedge funds and large institutions have $21.1M invested in Insight Molecular Diagnostics Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 11 closing their positions.
Holders
47
Holders Change
-5
Holders Change %
-9.62%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
13
Reduced
7
Closed
11
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K
Top Buyers
1 |
BC
1
Broadwood Capital
New York
|
$11.5M |
2 |
AIC
2
AWM Investment Company
New York
|
$3.26M |
3 |
3
Morgan Stanley
New York
|
$642K |
4 |
4
Citadel Advisors
Miami,
Florida
|
$57.9K |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$283K |